Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00307944 · ClinicalTrials.gov registry record · Phase 4
Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea
A Phase 4 study of Obstructive Sleep Apnea and Acid Reflux Disease, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT00307944: Completed Phase 4 study of Obstructive Sleep Apnea and Acid Reflux Disease, sponsored by University of Cincinnati.
NCT00307944 is a Phase 4 study of Obstructive Sleep Apnea and Acid Reflux Disease that has completed, run by University of Cincinnati. The registered enrollment target is 68 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00307944, a Phase 4 study of Obstructive Sleep Apnea and Acid Reflux Disease, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if using Pantoprazole decreases your daytime sleepiness and improves your reaction time when compared to using a placebo (sugar pill).
Conditions Studied
Interventions
- DRUG Pantoprazole
Study Locations (1)
Ohio
- University Ear, Nose and Throat Specialists - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2004-08 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
What the finished NCT00307944 record still lists
NCT00307944 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Pantoprazole is the first listed.
NCT00307944 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00307944 about?
NCT00307944 is a clinical study titled "Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea". The purpose of this study is to determine if using Pantoprazole decreases your daytime sleepiness and improves your reaction time when compared to using a placebo (sugar pill).
What is the current status of trial NCT00307944?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2004-08. Estimated completion is 2006-08.
What conditions does trial NCT00307944 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Acid Reflux Disease.
What interventions are being tested in trial NCT00307944?
The interventions under investigation include: Pantoprazole (DRUG).
Who is sponsoring clinical trial NCT00307944?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00307944 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00307944's enrollment target sits among peer trials
68 84th of 155 higher than 72 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics
RECRUITING · Phase 4
-
Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
COMPLETED · Phase 4
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
RECRUITING · Phase 1
-
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
RECRUITING
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia